REGENXBIO Inc. (NASDAQ: RGNX) shares are -12.47% down in the year-to-date (YTD) period and have moved -1.13% or -$0.41 lower in the latest trading session. Comparatively, the stock is down -22.48% over the trailing 3-month period. If we look at the shorter duration, its week performance is 4.73% and 30.40% over the month.
On June 18, 2019, Chardan Capital Markets recommended the RGNX stock is a Buy, while earlier, SVB Leerink had Upgrade the stock as a Mkt Perform on August 20, 2019. 6 analysts offering the recommendations for the stock have a consensus rating of 2.20 to suggest that the RGNX stock is a “Moderate Sell. 0 of the 6 analysts rate the stock as a “Sell”, while 0 has rated it as “Underweight”. 4 recommend buying, with 1 rating it as an Overweight.
The stock currently trades at $35.86 and analysts tracking its performance over the next 12 months have a consensus estimate price target of $75.50. The forecasts give the REGENXBIO Inc. stock a price target range of $150.00 on the higher side while at least one analyst think the stock could plunge to a low of $36.00. The two limits represent an upside potential of 76.09% or 0.39%.
Analysts estimate the earnings to decrease -63.60% in the current quarter to -$0.87, up from the -$0.89 reported in the same quarter a year ago. For the current year, earnings should grow to an average of -$1.84, up 324.20% from -$2.58 reported last year. Analysts also offered guidance for the next financial quarter, with their average projected EPS at between -$0.99 and -$0.35. Wall Street estimates earnings per share to be at an average of -$2.15 for the next year.
Insider Transactions Summary
According to SEC data, total insider shares purchases at the company stands at 29 over the last 12 months, while SEC filings reveal that there have been 35 insider sales over the same period. Insiders have purchases 222,604 shares while those sold by company executives and officers stand at 272,590. The last 3 months have seen insiders trade a total of 83,230 and 104,536 in purchases and sales respectively.
Simpson Curran, a SVP, Product Development & CTO at the company, sold 44,429 shares worth $2.23 million at $50.22 per share on Feb 10. The SVP, Product Development & CTO had earlier sold another 12,564 RGNX shares valued at $634411.0 on Feb 11. The shares were sold at $50.49 per share. Vasista Vittal (Chief Financial Officer) sold 14,806 shares at $50.07 per share on Feb 10 for a total of $741352.0 while HAYDEN DONALD J JR, (Director) sold 24,800 shares on Feb 10 for $1.24 million with each share fetching $50.11.
Deckers Outdoor Corporation (NYSE:DECK), on the other hand, is trading around $131.97 with a market cap of $3.68B and analyst research firms have a negative stance on its shares. Analysts predict that the stock will reach $184.73 and spell out a more modest performance – a 28.56% return. Some analysts are even forecasting $9.26 per share in earnings this year on a short term (1 year) basis.
Insiders have transacted a total of 30 times at Deckers Outdoor Corporation over the last 6 months, with insider purchases undertaken 17 times and accounting for 3,219 shares. Insider sales totaled 22,285 shares over the same period, with these deals completed in 13 transactions. Looking at these numbers, we realize that net purchases over that period are 4.0 shares. Insiders now hold a total of 305.06k shares after the latest sales, with -4.60% net shares purchased.
Insiders own 0.90% of the company shares with a share float percentage of 27.68M. Investors are also buoyed by the number of investors in a company, with Deckers Outdoor Corporation having a total of 498 institutions that hold shares in the company. The top two institutional holders are Blackrock Inc. with over 3.28 million shares worth more than $553.13 million. As of Dec 30, 2019, Blackrock Inc. held 11.70% of shares outstanding.
The other major institutional holder is Vanguard Group, Inc. (The), with the investment firm holding over 2.87 million shares as of Dec 30, 2019. The firm’s total holdings are worth over $484.95 million and represent 10.26% of shares outstanding.